Skip to main content

FDA panel unanimously recommends J&J Covid booster shots to adults who already got the first dose

   October 15, 2021

An influential FDA advisory committee on Friday said the agency should authorize boosters of Johnson & Johnson's single-shot COVID-19 vaccine to the more than 15 million Americans who have already received the initial dose.

Full story

Get the latest on healthcare leadership in your inbox.